Login

Comparison of the growth and monoclonal antibody production of suspended mammalian cells in three perfusion systems

Show simple item record

dc.contributor.advisor Jean-Francois Hamel. en_US
dc.contributor.author Hufford, Kathy (Kathy E.) en_US
dc.contributor.other Massachusetts Institute of Technology. Biological Engineering Division. en_US
dc.date.accessioned 2008-01-10T16:01:29Z
dc.date.available 2008-01-10T16:01:29Z
dc.date.copyright 2007 en_US
dc.date.issued 2007 en_US
dc.identifier.uri http://hdl.handle.net/1721.1/39921
dc.description Thesis (M. Eng.)--Massachusetts Institute of Technology, Biological Engineering Division, 2007. en_US
dc.description Includes bibliographical references (leaves 139-141). en_US
dc.description.abstract The purpose of this thesis was to provide a broad survey of bioprocess options for typical drug production vehicles in the biotechnology industry. This goal was accomplished by comparing the growth and monoclonal antibody production by HPCHO Chinese hamster ovary cells and IB4 hybridoma cells in batch, fed-batch, and three perfusion systems: the stirred ceramic membrane reactor (SCMR), the alternating tangential flow (ATF) hollow fiber membrane system, and the external spin filter (ESF) system. The batch experiments for each cell line were used as base case scenarios for the comparisons of cell growth and monoclonal antibody production. The fed-batch experiments for each cell line did not vastly improve the cell growth and monoclonal antibody production over the batch cases. The SCMR perfusion system greatly improved the cell growth and monoclonal antibody production for each cell line. The maximum viable cell concentration of the IB4 hybridoma cells in the SCMR experiment was over seven times that found in the batch experiment and the monoclonal antibody production in the SCMR experiment was over ten times that found in the batch experiment. en_US
dc.description.abstract (cont.) The ATF perfusion system greatly increased the cell growth for each cell line over the batch cases, but the shear forces created by the system adversely affected the viability of the cells and the monoclonal antibody production was less than that of the SCMR experiments. The ESF perfusion system damaged the HPCHO Chinese hamster ovary cells. For the production of the IB4 hybridoma cells, the ESF system, as well as a modified ESF system, did not vastly improve the cell growth and monoclonal antibody over the base case due to cell aggregation and filter fouling. The cell growth and productivity data, along with economic considerations, were evaluated for the purpose of recommending the best feeding strategy for each of the two cell lines studied. It was concluded that the most successful operation mode for the two cell lines studied was the SCMR perfusion system. More research is needed regarding the scale-up ramifications of the SCMR perfusion system as well as in the quantification of monoclonal antibodies, the optimization of fed-batch systems, and the use of alternative perfusion systems. en_US
dc.description.provenance Made available in DSpace on 2008-01-10T16:01:29Z (GMT). No. of bitstreams: 2 182626924.pdf: 9276541 bytes, checksum: ac1fa47750a0469d22f422e2107a8d0e (MD5) 182626924-MIT.pdf: 9276355 bytes, checksum: 74925b387522909eb92c4e0cb7785249 (MD5) Previous issue date: 2007 en
dc.description.statementofresponsibility by Kathy Hufford. en_US
dc.format.extent 141 leaves en_US
dc.language.iso eng en_US
dc.publisher Massachusetts Institute of Technology en_US
dc.rights M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. en_US
dc.rights.uri http://dspace.mit.edu/handle/1721.1/7582
dc.subject Biological Engineering Division. en_US
dc.title Comparison of the growth and monoclonal antibody production of suspended mammalian cells in three perfusion systems en_US
dc.type Thesis en_US
dc.description.degree M.Eng. en_US
dc.contributor.department Massachusetts Institute of Technology. Biological Engineering Division. en_US
dc.identifier.oclc 182626924 en_US

Files in this item

Files Size Format
Preview, non-printable (open to all) 9.276Mb application/pdf
Full printable version (MIT only) 9.276Mb application/pdf

This item appears in the following Collection(s)

Show simple item record

Search DSpace@MIT


Advanced Search

Browse

My Account

Links